Evidence map›Paper›PMID 29463549›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.

Kwanghee Kim, Philip A Watson, Souhil Lebdai, Sylvia Jebiwott, Alexander J Somma, Stephen La Rosa, Dipti Mehta, Katie S Murray, Hans Lilja, David Ulmert and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.Journal of experimental & clinical cancer research : CR · 2019
    Article
  12. Review
  13. Prostate cancer: Enhancing VTP.Nature reviews. Urology · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Kwanghee KimDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. kimk1@mskcc.org.
Philip A WatsonHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Souhil LebdaiDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Sylvia JebiwottDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Alexander J SommaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Stephen La RosaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Dipti MehtaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Katie S MurrayDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Hans LiljaGenitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
David UlmertMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Sebastien MonetteLaboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medicine, New York, New York.
Avigdor ScherzDepartment of Plants and Environmental Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Jonathan A ColemanDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
University of Oxford · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
SPORE In Prostate CancerP50CA092629 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI JAMES A EASTHAM · 2001 to 2026
$63.0M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA092629
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PhotochemotherapyAndrogen AntagonistsAndrogensAnimalsApoptosisBiomarkers, TumorCell Line, TumorCombined Modality TherapyDisease Models, AnimalGene Expression ProfilingHumansImmunohistochemistryMaleMiceNeovascularization, PathologicProstatic NeoplasmsAndrogen AntagonistsAndrogensBiomarkers, TumorReceptors, Androgen

Identifiers

PMID29463549
PMCPMC5955858
OpenAlexW2796774009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.